Singapore-UK Team To Develop a Novel Device to Reduce Chemotherapy Side-Effects Kumar Jeetendra | June 11, 2021 Singapore – 10 June 2021 – A team of clinicians and scientists from the National University Cancer Institute, Singapore (NCIS) at the National University Hospital (NUH) and the N.1 Institute for Health at the National University of Singapore (NUS) has partnered Paxman Coolers Ltd (UK) (Paxman) to develop a device that may prevent or reduce …
HiMedia introduces Mucormycosis detection kit, MUCOdiagno to isolate fungi from Mucormycosis patients Kumar Jeetendra | June 11, 2021 HiMedia Laboratories, a bioscience company with expertise in media manufacturing and diagnostics, has developed the Mucormycosis detection kit for mucormycosis patients. The kit has been introduced under the brand name MUCO-diagnoTM [K144], which is a complete kit for clinicians to collect the sample and isolate the fungi responsible for Mucormycosis from patient’s sample. Commenting on …
ENPICOM to integrate renowned structural antibody prediction tools developed at the University of Oxford Kumar Jeetendra | June 10, 2021 The Netherlands – June 10, 2021 – ENPICOM, an innovative bioinformatics software engineering company, announced the upcoming expansion of the IGX Platform’s capabilities towards advanced liability prediction. At the Antibody Engineering and Therapeutics virtual conference, the company revealed its plans to integrate the Structural Antibody Prediction Platform (SAbPred) developed by researchers at the University of …
3Brain AG CorePlate™ technology combines microchips and AI in a revolutionary new approach to drug discovery Kumar Jeetendra | June 8, 2021 Wädenswil, Greater Zurich Area, Switzerland, June 8, 2021 – – 3Brain AG has announced a new technology based on a unique combination of microchips and AI that promises to change the way drug candidates are selected at the preclinical level to enter into clinical trials – and to maximize their chances of success. Using CorePlate™ …
Algorics announces acquisition of Domain Clinical Data Sciences Kumar Jeetendra | June 7, 2021 New Jersey, USA – 7th June 2021 – Life Science Newswire – Algorics, a provider of biostatistics and programming solutions for the pharmaceutical and biotechnology industry, today announced the acquisition of Domain Clinical Data Sciences “DCDS”, a clinical data services organisation based in India. The acquisition supports Algorics’ commitment to expanding its team of experienced …
HiMedia: First Indian Company to get CDSCO Approval for Molecular Automated Instruments Kumar Jeetendra | June 4, 2021 HiMedia Laboratories proudly announces approval of the Insta NX Mag series of automated Extractors by the Central Drug Standard Control Organisation (CDSCO), India. We are extremely delighted to be the first and only Indian Company to obtain this certification for automated range of products. • Insta NX®Mag32 – LA1096 and • Insta NX® Mag 96 …
Eppendorf celebrates the 60th birthday of a pipetting masterstroke Kumar Jeetendra | May 28, 2021 2021 marks a key milestone for anyone working in a lab. Sixty years ago, Eppendorf changed the ways of handling liquids by introducing the world’s first piston-stroke pipette. Launched in 1961, the Eppendorf ‘Marburg Pipette’ featured the same basic elements as those found in today’s labs: a spring-loaded piston that stops precisely at a set …
Indica Labs and Ibex Partner to Deliver AI-powered Clinical Workflows for Digital Pathology Kumar Jeetendra | May 20, 2021 ALBUQUERQUE, NM and TEL AVIV, Israel – May 20, 2021 – Life Science Newswire – Indica Labs, an industry leader in quantitative digital pathology & image management solutions, and Ibex Medical Analytics, a pioneer in artificial intelligence (AI) based cancer diagnostics, announced an agreement to integrate the Galen™ AI-based cancer diagnostics platform into the HALO …
Lonza Launches Next Generation 4D-Nucleofector Cell Transfection Platform with Proven Performance and Enhanced Ease of Use Kumar Jeetendra | May 18, 2021 Basel, Switzerland, 18 May 2021 – Lonza has launched the next generation of its popular Nucleofector® Platform. For more than 20 years, Nucleofector® Technology has led the market as the most effective non-viral cell transfection method, which can be used even for hard-to-transfect cells, such as primary cells and pluripotent stem cells. Now, with an …
Prashant Nagre elevated to the position of Managing Director of Fermenta Biotech Limited Kumar Jeetendra | May 6, 2021 Mr Krishna Datla, Promoter and Managing Director of Fermenta Biotech Limited (FBL) today announced the appointment of Chief Executive Officer, Prashant Nagre, as the new Managing Director with effect from 9th May 2021. Mr Datla will continue as a Board member and the Executive Vice Chairman. The last few years have witnessed implementation of significant …
Takara Bio Europe AB and PanCryos Announce Licensing Agreement to Enable Development of Cell-Based Therapy for Diabetes Kumar Jeetendra | May 5, 2021 Göteberg, Sweden – May 05, 2021 – Life Science Newswire – Takara Bio Europe AB (TBEAB) and PanCryos are pleased to announce that they have reached a licensing agreement surrounding TBEAB’s clinical-grade human embryonic stem (hES) cell lines. PanCryos has established a simplified and effective method to generate stem cell-derived, glucose-responsive beta cells and is …
DefiniGEN appoints Dr Ben Cons as Chairman of its Board Kumar Jeetendra | April 29, 2021 Cambridge, UK – 29 April, 2021 – Life Science Newswire – DefiniGEN, the world leader in human induced pluripotent stem cell (iPSC) differentiation and disease modelling, today announces the appointment of Dr Ben Cons as Chairman of the Board. A respected entrepreneur and pharmaceutical and healthcare leader, he has a proven track record and brings …
